IDXX insider buying and SEC filings, explained
Idexx Laboratories Inc. · CIK 874716
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- In Vitro & In Vivo Diagnostic Substances
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$3.8M
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Mar 3, 2026 | Sale | Nimrata Hunt (Executive Vice President) sold 1,758 shares at about $634.57 ($1.1M). Holdings down 9% to 18,141 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 5, 2026 |
| Feb 26, 2026 | Sale | Nimrata Hunt (Executive Vice President) sold 2,693 shares at about $661.54 ($1.8M). Holdings down 12% to 19,899 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 27, 2026 |
| Feb 17, 2026 | Sale | Sophie V. Vandebroek (Director) sold 1,464 shares at about $628.62 ($920K). Holdings down 69% to 648 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 19, 2026 |
44 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Nov 2, 2026, 6:30 AM ET 8-K | Earnings released (Item 2.02) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow IDXX in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.